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Background: Mesoporous bioactive glasses (MBGs) are very attractive materials for use in 
bone tissue regeneration because of their extraordinarily high bone-forming bioactivity in vitro. 
That is, MBGs may induce the rapid formation of hydroxy apatite (HA) in simulated body 
fluid (SBF), which is a major inorganic component of bone extracellular matrix (ECM) and 
comes with both good osteoconductivity and high affinity to adsorb proteins. Meanwhile, the 
high bioactivity of MBGs may lead to an abrupt initial local pH variation during the initial Ca 
ion-leaching from MBGs at the initial transplant stage, which may induce unexpected nega-
tive effects on using them in in vivo application. In this study we suggest a new way of using 
MBGs in bone tissue regeneration that can improve the strength and make up for the weakness 
of MBGs. We applied the outstanding bone-forming bioactivity of MBG to coat the main ECM 
components HA and collagen on the MBG-polycarplolactone (PCL) composite scaffolds for 
improving their function as bone scaffolds in tissue regeneration. This precoating process can 
also expect to reduce initial local pH variation of MBGs.
Methods and materials: The MBG-PCL scaffolds were immersed in the mixed solution of 
the collagen and SBF at 37°C for 24 hours. The coating of ECM components on the MBG-PCL 
scaffolds and the effect of ECM coating on in vitro cell behaviors were confirmed.
Results: The ECM components were fully coated on MBG-PCL scaffolds after immersing 
in SBF containing dilute collagen-I solution only for 24 hours due to the high bone-forming 
bioactivity of MBG. Both cell affinity and osteoconductivity of MBG-PCL scaffolds were 
dramatically enhanced by this precoating process.
Conclusion: The precoating process of ECM components on MBG-PCL scaffold using a 
high bioactivity of MBG was not only effective in enhancing the functionality of scaffolds but 
also effective in eliminating the unexpected side effect. The MBG-PCL scaffold-coated ECM 
components ideally satisfied the required conditions of scaffold in tissue engineering, includ-
ing 3D well-interconnected pore structures with high porosity, good bioactivity, enhanced cell 
affinity, biocompatibility, osteoconductivity, and sufficient mechanical properties, and promise 
excellent potential application in the field of biomaterials.
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Introduction
Mesoporous materials synthesized via a sol-gel process and the supramolecular 
polymer templating methods are expected to have a range of applications in bioma-
terial science on account of their unique structural properties, including an ordered 
open pore structure ranging in size from 2 nm to 50 nm as well as a large specific 
surface area and pore volumes.1–4 Bone tissue regeneration is the latest   bioapplication 
using mesoporous materials.5–21 The large specific surface area and pore volume of International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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  mesoporous materials dramatically enhance their   bone-forming 
bioactive behavior and allow them to be loaded with osteo-
genic agents, thus promoting new bone formation, or with 
antibiotics for treatment purposes.5,6 The development of 
mesoporous bioactive glasses (MBGs) has increased the use 
of mesoporous materials in tissue regeneration based on their 
superior hydroxy apatite (HA) deposition performance, ie, 
greater bone-forming bioactivity in vitro, when compared 
with normal sol-gel-derived BGs.6 However, the meso-sized 
pores are too small to promote bone tissue regeneration. That 
is, MBGs are difficult to use alone as bone scaffolds for tis-
sue regeneration at this stage.10 The bone scaffold serves as 
a template for cell interactions and the formation of the bone 
extracellular matrix (ECM) for providing structural support 
to newly formed tissue.22–25 An ideal scaffold, therefore, 
should have bone-mimicking features such as high porosity 
with a pore size between 10 µm and 1000 µm with a 3D 
interconnected pore structure, bioactivity, biodegradability, 
and biocompatibility. Sufficient mechanical strength and ease 
of processability are also required to match the intended site 
of implantation and handling. To compensate for the weak 
structural properties of MBGs and make them applicable for 
tissue regeneration, our group proposed and successfully pre-
pared hierarchically 3D porous BG ceramic scaffolds using a 
combination of sol-gel, polymer templating, and rapid proto-
typing (RP) techniques, which can generate a physical model 
directly from computer-aided design data.10 Even though 
these newly proposed BG scaffolds addressed the structural 
limitations of MBGs, their mechanical   stability was lacking. 
For this, the development of a 3D porous MBG-polymer 
composite scaffold was constructed using the biodegrad-
able polymer poly ε-caprolactone (PCL).11 The MBG-PCL 
composite scaffolds possessed largely improved mechanical 
properties as well as molding capability, and they displayed 
effective in vitro bone-forming bioactivity. However, there 
still remain the problems to be solved not only relating to 
the high bioactivity of MBG accompanied with abrupt initial 
local pH variations, which may have unexpected negative 
effects such as cell damage when the scaffold is implanted 
in vivo, but also relating to the strong hydrophobicity of 
PCL, which may cause loss of cell recognition signaling.26,27 
To address these problems and improve the functionality of 
MBG as a bone scaffold, we applied the high bioactivity 
of MBG to coat biomimetic components on the surface of 
MBG-PCL scaffolds. That is, MBG may induce extraordi-
narily fast formation of HA on scaffolds in simulated body 
fluid (SBF), and we used this phenomenon to coat the main 
components of bone-ECM, HA, and collagen.
HA is a major inorganic component of bone ECM and has 
good osteoconductivity, high affinity to living cells, and the 
ability to adsorb proteins.27–29 Meanwhile, the major organic 
component of bone ECM is collagen, which promotes early 
cell adhesion and interacts with osteoblasts.28,30 The surface 
of the scaffolds plays an important role in interacting with 
host cells of tissue after implantation in situ.31 Surface coat-
ing of MBG-PCL scaffolds combined with HA and collagen 
may provide for better interactions between scaffolds and 
cells compared with bare MBG-PCL scaffolds, resulting in 
improved tissue regeneration. Furthermore, the precoating 
process of ECM components on MBG-PCL scaffolds not 
only may improve the hydrophilicity of MBG-PCL scaffolds 
but also may eliminate initial variation in pH.
Materials and methods
synthesis of MBg and preparation  
of gel paste for rapid prototyping
MBGs with 3D cubic pore structure were prepared according 
to our previously reported method.32 In a typical   synthesis, 
2.88 g of F127 is dissolved in 18.1 mL of EtOH. Stock 
solutions, which were prepared by mixing 1.36 g of calcium 
nitrate tetrahydrate, 0.26 mL of triethyl phosphate, 6 mL 
of tetraethyl orthosilicate, 0.95 mL of HCl (1 M), 7.62 mL 
of ethyl alcohol, and 2.86 mL of H2O, were added to this 
solution after stirring them for 1 hour separately and were 
vigorously stirred together for another 4 hours at 40°C. The 
reactant solution was transferred to a polystyrene   vessel 
without a cap and aged at 40°C 40% RH for 48 hours   without 
stirring. Gel films were obtained on evaporating the solvent. 
The obtained gel films were calcined at 600°C for 6 hours in 
air to remove the template. The MBGs were then ground and 
sieved. Granules with size below 25 µm were selected. PCL 
was dissolved in chloroform at 40°C, and the determined 
amounts of  MBG powders (60 wt% of  MBG to PCL) were 
then mixed with this to produce a homogeneous MBG-PCL 
paste. All chemicals were purchased from Sigma-Aldrich 
(St Louis, MO) and were used without further purification.
Fabrication of 3D scaffolds
The scaffolds were fabricated by directly extruding the gel 
paste onto a chilled substrate using a robotic deposition 
device.11 A gantry robotic deposition apparatus was used 
with specially altered systems such as an actuator to control 
the position of the deposition nozzle for the fabrication of the 
scaffold and a heat-controlled blowing system to maintain 
the 3D scaffold morphology, followed by the rapid evapora-
tion of the solvent. Three axes of motion control (x-, y-, and International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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z-axis) were provided by the gantry system, and a material 
delivery assembly composed of a syringe as a reservoir was 
affixed on the z-axis motion stage. The z-axis motion stage 
assembly was mounted on a moving gantry to enable the con-
trolled motion of the mounted syringe in three dimensions. 
The gel paste housed in the syringe was deposited through 
a cylindrical nozzle (24 G [≈500 µm] is generally used). 
A linear actuator served to depress the plunger of the syringe 
at a fixed speed such that the volumetric flow rate could be 
precisely controlled. The extruding strength and speed were 
adjusted to 50 µL/minute and 10 mm/second, respectively. 
The shapes and sizes of the scaffold can be designed at dis-
cretion and can be controlled by a computer system.
coating of ecM components
Collagen (type I [Col I]; Sigma-Aldrich, St Louis, MO) was 
dissolved in 0.1 M acetic acid (2 mg/mL). Two milliliters of 
this collagen solution was added to 200 mL of SBF. The SBF 
contained 142.0 mM Na+, 5 mM K+, 1.5 mM Mg2+, 2.5 mM 
Ca2+, 147.8 mM Cl-, 4.2 mM HCO3-, 1.0 mM HPO4
2-, and 
0.5 mM SO4
2-.33 Its chemical composition was similar to 
that of human plasma. The solution had a pH of 7.4 and 
was kept at 37°C before use. The MBG-PCL scaffolds were 
immersed in the mixed solution of the collagen-SBF at 37°C 
for 24 hours. After soaking, each scaffold was collected from 
the SBF, rinsed, and air dried.
characterization
Characterization of structure and cell morphology was carried 
out by field emission scanning electron microscopy (FE-SEM) 
(Hitachi-S5500; Hitachi, Tokyo, Japan and JEOL-5800, Tokyo, 
Japan). Cell morphology was also studied using a fluorescence 
microscope (BX51; Olympus, Tokyo, Japan) with Meta 
Morph software (Olympus) after incubating for 6 hours at a 
density of 3 × 104 cells/well. The compressive modulus was 
determined using a micro load system (R&B Inc, Daejeon, 
Korea) at a head speed of 0.5 mm/minute. The porosity was 
measured by the Hg intrusion method (AutoPore IV 9510; 
Micromeritics, Norcross, GA). Wettability was observed using 
the contact angle measurement system (Phoenix-300, Surface 
Electro Optics, Gyunggido, Korea) after dropping 10 µL of 
water onto each scaffold. X-ray photoelectron spectroscopy 
(XPS) (ESCALAB 250; Thermo Scientific, Waltham, MA) 
was used to study the scaffold surface with ALKα electron 
source. Protein concentration was measured using a protein 
assay kit (Coomassie Plus 23236; Thermo Scientific). The 
absorbance at 595 nm was read using a spectrophotom-
eter (Asys UVM 340; Biochrom, Holliston, MA).
cell culture
Cell culture experiments were performed using a mouse 
calvaria-derived preosteoblast MC3T3-E1 subclone 4 cell line 
obtained from American Type Cell Culture Collection (ATCC, 
Manassas, VA). Cells were maintained in α-minimum essen-
tial medium (Gibco BRL Life Technologies, Grand Island, 
NY) containing 10% fetal bovine serum (Gibco BRL Life 
Technologies), 100 U/mL penicillin (Keunhwa Pharmaceu-
tical, Seoul, Korea), and 100 U/mL streptomycin (Donga 
Pharmaceutical, Seoul, Korea). The cells were cultured 
under 100% humidity and 5% CO2 at 37°C. The medium was 
changed every other day and, prior to confluence, cells were 
passaged using 0.05% trypsin/0.02% EDTA.
Initial cell attachment and cell proliferation
Cell attachment and proliferation were evaluated by a 
colorimetric assay based on the conversion of a 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide 
(MTT, Sigma-Aldrich). MC3T3-E1 was seeded onto a 
square-shaped scaffold at a density of 1 × 105 cells/mL and 
cultured for 3 hours, 1 day, 3 days, 5 days, and 7 days. Each 
scaffold was prewetted in culture medium for at least 3 hours 
and then placed in a well plate.
Alkaline phosphate activity
Total cellular alkaline phosphate (ALP) activity of the cell 
lysates was measured in 2-amino-2-methyl-1-propanol 
  buffer, pH 10.3, at 37°C using p-nitrophenyl phosphate as 
the substrate. The absorbance change at 405 nm was mea-
sured using a microplate reader. ALP activity was expressed 
as nanomoles of p-nitrophenol liberated per microgram of 
total cellular protein.
Quantitative real-time polymerase  
chain reaction
Quantitative real-time polymerase chain reaction (PCR) was 
carried out using the Thermal Cycler Dice TP850 (Takarabio 
Inc, Shiga, Japan) according to the manufacturer’s protocol. 
Briefly, 2 µL of cDNA (100 ng), sense and antisense primer 
solution (1 µL, 0.4 µM), SYBR Premix Ex Taq (12.5 µL, 
Takarabio Inc), and dH2O (9.5 µL) were mixed together to 
obtain a final reaction mixture (25 µL) in each reaction tube. 
Quantitative real-time PCR was carried out with the follow-
ing primers: RUNX2 (s 5′-TAA GAA GAG CCA GGC AGG 
TG-3′; as 5′-TGG CAG GTA CGT GTG GTA GT-3′), Col 
1 (s 5′-ATC CAA CGA GAT CGA GCT CA-3′; as 5′-GGC 
CAA TGT CTA GTC CGA AT-3′), ALP (s 5′-CTT GAC TGT 
GGT TAC TGC TG-3′; as 5′-GAG CGT AAT CTA CCA TGG International Journal of Nanomedicine 2011:6
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AG-3′), OP (s 5′-TCA AGT CAG CTG GAT GAA CC-3′; 
as 5′-CTT GTC CTT GTG GCT GTG AA-3′), and OC 
(s 5′-TGC TTG TGA CGA GCT ATC AG-3′; as 5′-GTG 
ACA TCC ATA CTT GCA GG-3′). β-actin (s 5′-tag-3′; 
as 5′-TGG CAG GTA CGT GTG GTA GT-3′) was used to 
verify equal amounts of cDNA. The amplification conditions 
were 10 seconds at 95°C, 40 cycles of 5 seconds at 95°C and 
30 seconds at 60°C, 15 seconds at 95°C, 30 seconds at 60°C, 
and 15 seconds at 95°C. Relative quantification of mRNA 
expression was performed using the TP850 software.
statistical analysis
The results were expressed as mean ± standard deviation. 
Statistical analyses were performed using GraphPad Prism 
(GraphPad Software Institute, San Diego, CA). Treatment 
effects were analyzed using one-way analysis of variance. 
Significance was set at P , 0.05.
Results and discussion
coating of ecM components  
on MBg-PcL scaffolds
The synthetic strategy is illustrated in Scheme 1. We pre-
liminarily prepared 3D MBG-PCL scaffolds according to our 
previously reported method.11 The pore size and the porosity of 
MBG-PCL scaffolds was about 500 µm and 70%, respectively, 
with well-interconnected pores in three dimensions. The scaf-
folds were immersed in SBF containing dilute Col I solution 
at 37°C for 24 hours to form HA/collagen composite coatings 
on the scaffolds using high bioactivity of MBG (designated by 
ECM-coated scaffold). The abrupt initial local pH variations 
occurred during this stage because of initial release of Ca 
ions from the MBG. MBGs facilitate the rapid and massive 
release of Ca ions and subsequently induce high bioactivity.6 
Both Ca and P ions play an important role in promoting the 
formation of an extracellular mineralized matrix.34 However, 
this property may also induce serious negative effects such 
as an inflammatory response, due to the sudden change of 
the pH value.18,29,35,36 The abrupt initial pH variations were 
largely reduced during the biomimetic coating process and 
may reduce negative effects from the abrupt pH variation in 
vivo. The pH value of the solution for ECM-coated scaffolds 
after 1 day of immersion was around 8, whereas the pH value 
for MBG-PCL scaffolds was around 9.8 (Figure 1A).
The surface morphology of the MBG-PCL scaffolds 
started to change after treatment with SBF/collagen solution 
for 4 hours (see Figure S1). The MBG-PCL scaffolds immersed 
in SBF/collagen solution for 24 hours exhibited a rough sur-
face morphology with fully covered HA-like particles and 
collagen fibers (Figure 2C and 2D, and Figure S2), whereas 
uncoated MBG-PCL scaffolds had a smooth surface morphol-
ogy (Figure 2A and B). The formation of HA and collagen 
composites on the surface of the scaffolds was also confirmed 
by XPS, as shown in Figure 1B. Only weak Ca (345 eV) and 
Si (152 eV) peaks were detected from MBG-PCL scaffolds, 
proving the nonexistence of  HA before the coating process. 
The weak peaks suggest that many parts of MBG were masked International Journal of Nanomedicine 2011:6
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by PCL during the RP extrusion process, although the scaffolds 
still exhibited high bioactivity from MBG. Several sharp Ca 
and P peaks in the XPS spectra of the ECM-coated scaffolds 
were newly detected, suggesting the formation of HA on the 
surface of the scaffolds.28 In addition, the detection of an N 
peak around 397 eV provided evidence of the presence of Col 
I on the surface of the ECM-coated scaffolds. Interestingly, a 
larger amount of collagen (5.5 ± 0.7 µg cm-3) adsorbed to the 
MBG-PCL scaffold by the coprecipitation process of collagen 
and HA in SBF, compared with the scaffold coated only with 
single collagen in aqueous condition (3.2 ± 0.2 µg cm-3) under 
the same conditions such as concentration of collagen and 
immersing time, possibly due to high interactions between HA 
and collagen from good protein affinity of HA (Figure 3).37
The wettability of the material surface is one of the 
key parameters affecting the adhesion and spreading of 
osteoblastic cells and determines subsequent processes 
such as cell morphology, proliferation, and differentiation.38 
Osteogenic cells tend to prefer hydrophilic surfaces rather 
than   hydrophobic surfaces. To test the effects of ECM com-
ponent coating on the wettability of scaffolds, we prepared 
scaffolds without pores by extruding paste in succession 
using RP systems (Figure S3). The water contact angle of 
the MBG-PCL scaffolds after applying water droplets for 
60 seconds was 74.3°, whereas the water contact angle of 
PCL was 81.3°. The hydrophilicity of PCL improved by mix-
ing with MBG but remained low due to limited exposure of 
MBG on the scaffold surface. Meanwhile, the water contact 
angle of the ECM-coated scaffolds was dramatically changed 
to 20.1°, suggesting that the hydrophilicity of the scaffolds 
significantly improved by coating with the ECM components 
(Figure 4A–C). The hydrophilic surface of the scaffolds may 
have been responsible for the increase in cell attachment 
and osteoconduction. The mechanical properties of the 
MBG-PCL scaffolds did not decrease during the biomimetic International Journal of Nanomedicine 2011:6
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cell growth on the MBG-PCL- and ECM-coated scaffolds 
after 6 hours of incubation, respectively. A higher degree 
of cell extension and growth was observed in the cells on 
ECM-coated   scaffolds than MBG-PCL, proving the positive 
efficiency of ECM component coating on cell attachment 
and growth.
The initial cell attachment efficiency after 3 hours of incu-
bation, evaluating MTT study, proved the favorable effect of 
ECM coating (Figure 5A). The highest rate of cellular attach-
ment was observed in the ECM-coated scaffolds, whereas 
the PCL scaffolds showed the lowest rate. There was also a 
clear difference in the cell proliferation   behaviors of scaffolds 
depending on their surface properties for all testing periods 
from 1 to 7 days of culture (Figure 5B). The ECM-coated 
scaffolds displayed the highest increase in the number of cells 
for all proliferation periods, indicating meaningful effect of 
the ECM components on the cell proliferation behavior.
The most notable effect of ECM coating was observed on 
the osteoblast differentiation behavior. The differentiation of 
cells cultured on PCL-, MBG-PCL-, and ECM-coated scaf-
folds was assessed in terms of the ALP activity of MC3T3-E1 
cells at 3, 7, and 14 days as shown in Figure 5C. It is known 
that the ALP activity of MC3T3-E1 cells increases after 
differentiation and then decreases at the beginning of cell 
mineralization.41 The ALP activity of the ECM-coated sample 
significantly increased at Day 7 and then decreased, indicating 
the upregulated osteoblastic differentiation of the cells at Day 
7 and the start of cell mineralization at Day 14, whereas the 
ALP activities of both PCL and MBG-PCL scaffolds slowly 
increased throughout the entire tested periods. To check the 
effect of each ECM component on differentiated osteoblast 
functions, the ALP activity of MC3T3-E1 cells cultured 
on the MBG-PCL scaffolds coated with HA and collagen 
was also assessed separately for the same culturing periods 
(Figure 6). ALP level in HA-coated scaffolds was largely 
increased at Day 7, whereas the ALP level in collagen-coated 
scaffolds was increased at Day 14. Both coating of HA and 
collagen on MBG-PCL scaffolds is effective in enhancing 
the differentiation of cells, but HA initiates an earlier stage 
of differentiation than collagen. Meanwhile, the coating of 
both HA and collagen at the same time by our coprecipita-
tion method using high bioactivity of MBG could promote 
the synergistic effect of both components and lead to a much 
better effect on inducing differentiation of osteoblast cells 
than the coating of individual components. The differences 
of ALP activity of MBG-PCL scaffolds with a different 
ECM component coating condition are mainly caused by 
the different effect of each component on the cell functions, 
coating process. The compressive moduli of the MBG-PCL 
and the ECM-coated scaffolds were 17.2 ± 2.4 MPa and 
17.1 ± 1.9 MPa, respectively.
effect of ecM component coating  
on the preosteoblast cell behavior
HA generally plays a key role in bone bonding with BG, 
and HA/collagen promotes the early stage of proliferation, 
differentiation, and bone mineralization.27,29,39,40 The effects 
of coating with ECM components on cellular behavior were 
evaluated in vitro by studying the behavior of mouse calva-
ria-derived preosteoblast MC3T3-E1 cells. The spreading 
of cells at the initial stage is an important step for essential 
biological processes such as proliferation.29 The improved 
hydrophilicity of the scaffolds greatly affected the enhance-
ment of initial cell affinity. Figure 4D–F shows the adhe-
sion and spreading morphology of MC3T3-E1 cells on the 
PCL-, MBG-PCL-, and ECM-coated scaffolds after 30 min-
utes of incubation. Cells on the PCL scaffolds were spherical 
in shape without spreading, whereas the appearance of cells 
on MBG-PCL scaffolds were more spread out with numerous 
filopodia and lamellipodia. Faster attachment, higher degree 
of cell extension, and flattened morphology with numerous 
filopodia and lamellipodia were observed in the cells on 
ECM-coated scaffolds, proving the high efficiency of ECM 
coating on initial cell attachment. Similar phenomena can 
be confirmed by fluorescent microscopic images. Figure 4G 
and H shows top view fluorescent microscopic images of International Journal of Nanomedicine 2011:6
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because all scaffolds were treated using the precoating pro-
cess under the same conditions, which may reduce abrupt 
initial pH variation.
Similar results were obtained from real-time PCR analy-
sis at 4 and 7 days, as shown in Figure 7. Key osteoblast 
genes, such as RUNX2, Col I, ALP, osteopontin (OP), and 
  osteocalcine (OC), were selected to evaluate the defect in 
the differentiation process at mRNA level.42–44 RUNX2 is the 
master gene in osteogenesis and is the key transcription fac-
tor regulating osteoblast differentiation.45 The expression of 
RUNX2 in all of the samples steadily increased over time. In 
particular, ECM-coated scaffolds expressed the highest level 
of RUNX2 from the early stage at Day 4. Col 1 is regularly 
used as an early marker of osteoblast differentiation. The 
level of Col 1 in the ECM-coated scaffolds was the highest 
at Day 4 but downregulated at Day 7 when differentiation 
started. ALP is another early-stage marker of osteoblast 
differentiation and function in making phosphate available 
for calcification. ALP was expressed at the same level in 
both the MBG-PCL- and ECM-coated scaffolds, whereas 
it was expressed much lower in the PCL scaffold at Day 4. 
ALP of the ECM-coated scaffolds was expressed at the 
highest level after 7 days. OP is a mineral-binding protein 
found in bone ECM. It associates with biomineralization of 
ECM into bone and is often used as a middle-stage marker 
of osteogenic differentiation. The OP level of ECM-coated 
scaffold was expressed the highest throughout the study 
and significantly increased at Day 7. OC is secreted by 
osteoblasts and plays a role in   mineralization and calcium International Journal of Nanomedicine 2011:6
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Figure 7 Quantitative real-time polymerase chain reaction analysis of rUNX2, collagen-I, ALP, OP, and Oc mrNA expression in cells grown on each scaffold at 4 (A) and 
7 (B) days of culture.
Note: Data are presented as the mean ± standard deviation (at least n = 3 samples per group). Differentiation from ecM-coated scaffolds (*P , 0.05, **P , 0.01, and 
***P , 0.001).
Abbreviations: ALP, alkaline phosphate; ecM, extracellular matrix; MBg, mesoporous bioactive glass; Oc, osteocalcine; OP, osteopontin; PcL, polycarplolactone.
AB
C
100 µm 100 µm
100 µm 100 µm
D
1st
3rd
2nd
4th
Figure 8 Field emission scanning electron microscopy images of extracellular matrix-
coated scaffolds after 5 days of culture of MC3T3-E1 cell: first (A), second (B), third 
(C), and fourth layer (D).
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ion homeostasis.   Consequently, it is often used as a terminal 
marker of osteoblast differentiation. The highest level of 
OC was observed in ECM-coated scaffolds at Day 7. The 
early increased expression of OP and OC in cells grown 
on ECM-coated scaffolds may be due to the fact that min-
eralization occurred much sooner. That is, the presence of 
ECM components may have been the key factor promoting 
stimulation of the osteogenic differentiation of osteoblast 
cells. These results also show that our suggested coating 
process on MBG/PCL scaffolds was effective in enhanc-
ing the applicability of MBG/PCL scaffolds to bone tissue   
regeneration.
The advantage of using an RP technique to produce 3D 
scaffolds is the construction of a highly porous and well-
interconnected 3D structure.46,47 These structural properties 
allow efficient cell migration, vascularization, and tissue 
in-growth. The 3D cell movement is essential for 3D tissue 
in-growth through 3D scaffolds. Meanwhile, the surface 
properties of 3D scaffolds are also important for promoting 
sufficient tissue regeneration. The ECM-coated scaffolds 
display good cell affinity and consequently promote good 
cell migration as well as penetration within the interior of 
the 3D scaffolds. Figure 8 shows top view FE-SEM images 
of cells on the ECM-coated scaffolds after 5 days of incuba-
tion. The morphology and distribution of the cells on each 
strut were similar from the first layer (Figure 8A) to the 
fourth layer (Figure 8D), indicating good cell penetration 
into ECM-coated scaffolds. Figure 9 shows FE-SEM images 
of the PCL-, MBG-PCL-, and ECM-coated scaffolds before 
and after 21 days of cell culture. Although all three scaf-
folds had the same structure, their cell growth progressed 
differently. Less tissue sheet formation was observed on the 
PCL scaffold, especially within the interface of each strut 
(Figure 9A). The MBG-PCL scaffold showed the formation 
of denser cell sheets compared with the PCL, and therefore 
better function as a bone scaffold (Figure 9B). In contrast, 
there was greater dense cell and tissue sheet formation on 
the ECM-coated scaffolds, revealing a significant role for 
ECM components in tissue distribution (Figure 9C). These 
results suggest that the biomimetic ECM component coat-
ing process on MBG/PCL scaffold using a high bioactivity 
of MBG is effective for enhancing proliferation, osteogenic 
differentiation, penetration, and growth of cells, and provides 
high potential possibilities of MBG/PCL scaffolds in the field 
of bone tissue regeneration.International Journal of Nanomedicine 2011:6
KIMS LEI 5.0 kV X40 WD 7.2 mm 100 µm
KIMS LEI 5.0 kV X40 WD 7.9 mm 100 µm
KIMS LEI 5.0 kV X40 WD 9.3 mm 100 µm
KIMS LEI 5.0 kV X40 WD 6.1 mm 100 µm
KIMS LEI 5.0 kV X40 WD 9.2 mm 100 µm
KIMS LEI 5.0 kV X40 WD 8.6 mm 100 µm
A
Day 0 Day 21
B
C
PCL
MBG-PCL
ECM-coated
Figure 9 Field emission scanning electron microscopy images of cell growth before (left) and after 21 days (right) of culture of Mc3T2-e1 cells on polycarplolactone (PcL), 
mesoporous bioactive glass (MBg)-PcL, and extracellular matrix (ecM)-coated scaffolds.
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Conclusion
A scaffold must meet several specific requirements to achieve 
the goal of bone reconstruction. Ideal scaffolds should have 
several features, including high porosity with 3D intercon-
nected pore structures, bioactivity, biodegradability, bio-
compatibility, osteoconductivity, and sufficient mechanical 
properties. Our proposed scaffolds ideally satisfied these 
conditions. That is, the RP technique provided an easily 
controllable and highly interconnected 3D pore structure 
with 70% porosity. MBG supplied high bioactivity, and 
both MBG and PCL were found to be biodegradable and 
biocompatible. The combination of MBG and PCL may 
have provided enhanced mechanical properties compared 
with the case of using each material alone. ECM component 
coating using high bioactivity of MBG on the MBG-PCL 
scaffolds promoted high osteoconductivity. This biomimetic 
coating process was also helpful in preventing negative 
effects of local pH variations during the initial ion-leaching. 
The mesoporosity of MBG should also make possible the 
controlled release of drugs into scaffolds. We hope that 
this simple and reproducible process can be adapted for the 
preparation of various scaffolds for use in tissue regeneration. 
More detailed studies in vivo are currently in progress.
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Supplementary figures
Figure S1 Field emission scanning electron microscopy images of mesoporous bioactive glass and polycarplolactone scaffold surface after immersing in simulated body fluid 
collagen solution for 4 hours (left) and 24 hours (right).
Figure S2 electrodiagnostic studies corresponding to the surface of mesoporous bioactive glass and polycarplolactone scaffolds before (top) and after (bottom) extracellular 
matrix component coating.
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Figure S3 sample preparation method for testing water contact angle.
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